Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

N/ACompletedNCT00185913

Stanford University50 enrolled

Overview

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Lung Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors Exclusion Criteria:- Patients without non-small cell lung cancer

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.